Liposomes loaded with paclitaxel and modified with novel triphenylphosphonium-PEG-PE conjugate possess low toxicity, target mitochondria and demonstrate enhanced antitumor effects in vitro and in vivo

Abstract
No abstract available
Funding Information
  • NIH (RO1 CA121838, RO1 CA 128486)